Epigenetics in Health and Disease, Volume 198 in the Progress in Molecular Biology and Translational Science series, highlights new advances in the field, with this new volume presenting interesting chapters on Computational biology in epigenetics, Artificial intelligence and machine learning in epigenetics, CRISPR-dCas9 Systems for Epigenetic Editing for Therapeutic Applications, Epigenetics in heredity disease, Epigenetics in cancer development, diagnosis and therapy, Microbiota and epigenetics: health impact, Histone deacetylase (HDACs) Inhibitors: Clinical applications, Early epigenetic markers for precision medicine, Epigenetics of neurological diseases, Epigenetic Regulons in Alzheimer’s disease, and Epigenetics in epilepsy.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Preface - p. xiii 7. Chapter One: Applications of bioinformatics in epigenetics - p. 1 8. Chapter Two: CRISPR-dCas9 system for epigenetic editing towards therapeutic applications - p. 15 9. Chapter Three: Epigenetic control of heredity - p. 44 10. Chapter Four: Epigenetics in renal diseases - p. 61 11. Chapter Five: Epigenetics in cancer development, diagnosis and therapy - p. 73 12. Chapter Six: Microbiota and epigenetics: Health impact - p. 93 13. Chapter Seven: Histone deacetylase (HDACs) inhibitors: Clinical applications - p. 119 14. Chapter Eight: Early epigenetic markers for precision medicine - p. 153 15. Chapter Nine: Epigenetics of neurological diseases - p. 165 16. Chapter Ten: Epigenetic regulons in Alzheimer's disease - p. 203 17. Chapter Eleven: Epigenetics in epilepsy - p. 249 18. Index - p. 269
Epigenetics in Health and Disease, Volume 198 in the Progress in Molecular Biology and Translational Science series, highlights new advances in the field, with this new volume presenting interesting chapters on Computational biology in epigenetics, Artificial intelligence and machine learning in epigenetics, CRISPR-dCas9 Systems for Epigenetic Editing for Therapeutic Applications, Epigenetics in heredity disease, Epigenetics in cancer development, diagnosis and therapy, Microbiota and epigenetics: health impact, Histone deacetylase (HDACs) Inhibitors: Clinical applications, Early epigenetic markers for precision medicine, Epigenetics of neurological diseases, Epigenetic Regulons in Alzheimer’s disease, and Epigenetics in epilepsy.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Preface - p. xiii 7. Chapter One: Applications of bioinformatics in epigenetics - p. 1 8. Chapter Two: CRISPR-dCas9 system for epigenetic editing towards therapeutic applications - p. 15 9. Chapter Three: Epigenetic control of heredity - p. 44 10. Chapter Four: Epigenetics in renal diseases - p. 61 11. Chapter Five: Epigenetics in cancer development, diagnosis and therapy - p. 73 12. Chapter Six: Microbiota and epigenetics: Health impact - p. 93 13. Chapter Seven: Histone deacetylase (HDACs) inhibitors: Clinical applications - p. 119 14. Chapter Eight: Early epigenetic markers for precision medicine - p. 153 15. Chapter Nine: Epigenetics of neurological diseases - p. 165 16. Chapter Ten: Epigenetic regulons in Alzheimer's disease - p. 203 17. Chapter Eleven: Epigenetics in epilepsy - p. 249 18. Index - p. 269
